Biogen and Eisai reported the finding from a large late-stage clinical trial of lecanemab, a drug they are developing.
Author: Rebecca Robbins and Pam Belluck
Advertisements
{
"slotId": "6845006044",
"unitType": "responsive",
"resize": "auto"
}